| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681621 | Clinical Neurology and Neurosurgery | 2018 | 7 Pages |
Abstract
Our study suggested that tacrolimus could be an effective and safe treatment for Osserman grade III and Osserman grade IV MG patients.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Li-Na Zhao, Yi Liang, Xue-Jun Fang, Xiao-Man Liu, Qi-Long Jiang, Shuang-Shuang Wang, Shi-Feng She, Min Cao,